Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Nilsson

Showing results (131-140 of 211) with videos related to

Pageof 22
Sort By:
BJS Open|July 3, 2026
Pattern of lymph node spread in gastric cancer: Western multicenter retrospective studyFrancesca Blasa, Giuseppe Verlato, Hidde Overtoom, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2020
Palliation of dysphagia in metastatic oesogastric cancers: An international multidisciplinary positionAntonin Levy, Anna D Wagner, Cyrus Chargari, et al.
Annals of Surgical Oncology|March 3, 2026
ASO Visual Abstract: Patterns, Timing, and Survival of Recurrence After Surgery for Esophageal and Junctional Adenocarcinoma in the European Multicenter ENSURE StudyLucas Goense, Jessie A Elliott, Sheraz R Markar, et al.
Annals of Surgical Oncology|November 1, 2025
Evaluating Organotrophic Risk Factors, Time to Development, and Outcomes of Solitary Brain Metastasis After Esophagectomy: A Multicenter Cohort StudyStijn Vanstraelen, Johnny Moons, Xing Gao, et al.
Annals of Surgical Oncology|April 6, 2026
Patterns, Timing, and Survival of Recurrence After Surgery for Esophageal and Junctional Adenocarcinoma in the European Multicentre ENSURE StudyLucas Goense, Jessie A Elliott, Sheraz R Markar, et al.
Journal of Medicinal Chemistry|January 23, 2014
Discovery and development of simeprevir (TMC435), a HCV NS3/4A protease inhibitorÅsa Rosenquist, Bertil Samuelsson, Per-Ola Johansson, et al.
Angewandte Chemie (International Ed. in English)|February 19, 2010
Induced-fit binding of the macrocyclic noncovalent inhibitor TMC435 to its HCV NS3/NS4A protease targetMaxwell D Cummings, Jimmy Lindberg, Tse-I Lin, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2008
Discovery of novel potent and selective dipeptide hepatitis C virus NS3/4A serine protease inhibitorsPierre Raboisson, Tse-I Lin, Herman de Kock, et al.
Annals of Surgery|July 20, 2023
Neoadjuvant Chemoradiotherapy Versus Chemotherapy for the Treatment of Locally Advanced Esophageal Adenocarcinoma in the European Multicenter ENSURE StudyJessie A Elliott, Fredrik Klevebro, Styliani Mantziari, et al.
The British Journal of Surgery|January 13, 2022
Outcomes after totally minimally invasive versus hybrid and open Ivor Lewis oesophagectomy: results from the International Esodata Study GroupBerend J van der Wilk, Eliza R C Hagens, Ben M Eyck, et al.
Pageof 22

Showing results (131-140 of 211) with videos related to

Sort By:
Pageof 22
BJS Open|July 3, 2026
Pattern of lymph node spread in gastric cancer: Western multicenter retrospective studyFrancesca Blasa, Giuseppe Verlato, Hidde Overtoom, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2020
Palliation of dysphagia in metastatic oesogastric cancers: An international multidisciplinary positionAntonin Levy, Anna D Wagner, Cyrus Chargari, et al.
Annals of Surgical Oncology|March 3, 2026
ASO Visual Abstract: Patterns, Timing, and Survival of Recurrence After Surgery for Esophageal and Junctional Adenocarcinoma in the European Multicenter ENSURE StudyLucas Goense, Jessie A Elliott, Sheraz R Markar, et al.
Annals of Surgical Oncology|November 1, 2025
Evaluating Organotrophic Risk Factors, Time to Development, and Outcomes of Solitary Brain Metastasis After Esophagectomy: A Multicenter Cohort StudyStijn Vanstraelen, Johnny Moons, Xing Gao, et al.
Annals of Surgical Oncology|April 6, 2026
Patterns, Timing, and Survival of Recurrence After Surgery for Esophageal and Junctional Adenocarcinoma in the European Multicentre ENSURE StudyLucas Goense, Jessie A Elliott, Sheraz R Markar, et al.
Journal of Medicinal Chemistry|January 23, 2014
Discovery and development of simeprevir (TMC435), a HCV NS3/4A protease inhibitorÅsa Rosenquist, Bertil Samuelsson, Per-Ola Johansson, et al.
Angewandte Chemie (International Ed. in English)|February 19, 2010
Induced-fit binding of the macrocyclic noncovalent inhibitor TMC435 to its HCV NS3/NS4A protease targetMaxwell D Cummings, Jimmy Lindberg, Tse-I Lin, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2008
Discovery of novel potent and selective dipeptide hepatitis C virus NS3/4A serine protease inhibitorsPierre Raboisson, Tse-I Lin, Herman de Kock, et al.
Annals of Surgery|July 20, 2023
Neoadjuvant Chemoradiotherapy Versus Chemotherapy for the Treatment of Locally Advanced Esophageal Adenocarcinoma in the European Multicenter ENSURE StudyJessie A Elliott, Fredrik Klevebro, Styliani Mantziari, et al.
The British Journal of Surgery|January 13, 2022
Outcomes after totally minimally invasive versus hybrid and open Ivor Lewis oesophagectomy: results from the International Esodata Study GroupBerend J van der Wilk, Eliza R C Hagens, Ben M Eyck, et al.
Pageof 22